Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Adlai Nortye Ltd. - American Depositary Shares
(NQ:
ANL
)
12.48
-0.60 (-4.59%)
Streaming Delayed Price
Updated: 9:35 AM EDT, Aug 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Adlai Nortye Ltd. - American Depositary Shares
Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia
August 03, 2026
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025
July 16, 2026
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists
July 13, 2026
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Announces $150.0 Million Private Placement Equity Financing
April 16, 2026
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations
February 12, 2026
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Announces $140.0 Million Private Placement Equity Financing
February 03, 2026
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China
December 29, 2025
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye to Participate in Upcoming Investor Conferences
November 21, 2025
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye to Present Short Talk on AN4035 Preclinical Results at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 22, 2025
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 13, 2025
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye to Present Research Findings at AACR Annual Meeting 2025
April 10, 2025
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Reports Unaudited First Half 2024 Financial Results and Highlights Recent Operational Progress
August 08, 2024
Company Announces Appointment of Roger Sawhney, M.D. as a New Member of the Board of Directors
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Appoints Roger Sawhney, M.D. to Its Board of Directors
August 08, 2024
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024
May 23, 2024
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy
May 22, 2024
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development
March 29, 2024
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC
November 17, 2023
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award
October 23, 2023
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Ltd. Announces Closing of Initial Public Offering
October 03, 2023
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
